Larimar Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Larimar Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2013 to Q2 2024.
  • Larimar Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.97M, a 137% increase year-over-year.
  • Larimar Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $7.5M, a 110% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.81M, a 311% increase from 2022.
  • Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.17M.
  • Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$171K, a 153% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.5M $2.97M +$1.72M +137% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.78M $2.08M +$969K +87.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.81M $1.17M +$155K +15.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $4.65M $1.28M +$1.08M +561% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.57M $1.25M +$1.23M +6170% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $2.34M $1.11M +$1.17M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.17M $1.01M +$1.06M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $109K $193K +$268K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$159K $20K +$86K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$245K -$56K -$74K -411% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$171K -$48K -$275K -121% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $104K -$75K -$136K -223% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $240K -$66K -$135K -196% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $375K $18K +$53K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $322K $227K +$363K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$41K $61K +$69K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$110K $69K +$8K +13.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$118K -$35K -$200K -121% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $82K -$136K -$257K -212% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $339K -$8K -$110K -108% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $449K $61K +$276K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $173K $165K +$419K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$246K $121K -$152K -55.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$94K $102K -$153K -60% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $59K -$215K -$404K -214% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $463K -$254K -$508K -200% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $971K $273K +$237K +658% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $734K $255K +$99K +63.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $635K $189K +$155K +456% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $480K $254K +$133K +110% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $347K $36K -$36K -50% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 $383K $156K +$323K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $60K $34K +$180K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$120K $121K +$353K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$473K $72K +$339K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$812K -$167K +$161K +49.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$973K -$146K +$268K +64.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 -$1.24M -$232K -$295K -468% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$946K -$267K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$328K -$348K -1740% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$414K -$253K -157% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $63K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $20K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$161K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.